Fatemeh Davami

666 total citations
54 papers, 511 citations indexed

About

Fatemeh Davami is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Fatemeh Davami has authored 54 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 16 papers in Oncology and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Fatemeh Davami's work include Viral Infectious Diseases and Gene Expression in Insects (27 papers), Monoclonal and Polyclonal Antibodies Research (16 papers) and CAR-T cell therapy research (12 papers). Fatemeh Davami is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (27 papers), Monoclonal and Polyclonal Antibodies Research (16 papers) and CAR-T cell therapy research (12 papers). Fatemeh Davami collaborates with scholars based in Iran, United States and Spain. Fatemeh Davami's co-authors include Farzaneh Barkhordari, Fereidoun Mahboudi, Behrouz Vaziri, Fereidoun Mahboudi, Fatemeh Torkashvand, Keivan Majidzadeh‐A, Vahid Khalaj, Ahmad Adeli, Amir Heydari and Manouchehr Vossoughi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Fatemeh Davami

51 papers receiving 502 citations

Peers

Fatemeh Davami

RNMI

GENET

ONCOL

BIOTE

Abdul Qader Abbady Syria

Tharmala Tharmalingam Ireland

Maureen Spearman Canada

Masako Mori Japan

Uli Binder Germany

Mitra Ahmadi France

Yujing Sun China

Husain Attarwala United States

Hervé Nozach France

Mohammad M. Farajollahi Iran

Abdul Qader Abbady Syria

Fatemeh Davami

397 ×1.1

126 ×0.9

RNMI

46 ×0.5

GENET

61 ×0.7

ONCOL

37 ×0.5

BIOTE

Citations per year, relative to Fatemeh Davami Fatemeh Davami (= 1×) peers Abdul Qader Abbady

Countries citing papers authored by Fatemeh Davami

Since Specialization

Citations

This map shows the geographic impact of Fatemeh Davami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatemeh Davami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatemeh Davami more than expected).

Fields of papers citing papers by Fatemeh Davami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatemeh Davami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatemeh Davami. The network helps show where Fatemeh Davami may publish in the future.

Co-authorship network of co-authors of Fatemeh Davami

This figure shows the co-authorship network connecting the top 25 collaborators of Fatemeh Davami. A scholar is included among the top collaborators of Fatemeh Davami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatemeh Davami. Fatemeh Davami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barkhordari, Farzaneh, et al.. (2024). CHO cell engineering via targeted integration of circular miR-21 decoy using CRISPR/RMCE hybrid system. Applied Microbiology and Biotechnology. 108(1). 434–434. 2 indexed citations

Barkhordari, Farzaneh, et al.. (2024). Anti-IL-1RAP scFv-mSA-S19-TAT fusion carrier as a multifunctional platform for versatile delivery of biotinylated payloads to myeloid leukemia cells. Scientific Reports. 14(1). 25080–25080. 1 indexed citations

Ghassempour, Alireza, et al.. (2023). Production and characterization of a camelid single domain anti-CD22 antibody conjugated to DM1. Molecular and Cellular Biochemistry. 479(3). 579–590. 7 indexed citations

Davami, Fatemeh, et al.. (2023). CRISPR‐interceded CHO cell line development approaches. Biotechnology and Bioengineering. 120(4). 865–902. 7 indexed citations

Bayat, Elham, Hooman Aghamirza Moghim Aliabadi, Soroush Sardari, et al.. (2022). Bacterial production and biophysical characterization of a hard-to-fold scFv against myeloid leukemia cell surface marker, IL-1RAP. Molecular Biology Reports. 50(2). 1191–1202. 3 indexed citations

Bayat, Elham, et al.. (2021). Targeted integration into pseudo attP sites of CHO cells using CRISPR/Cas9. Journal of Biotechnology. 337. 1–7. 10 indexed citations

Barkhordari, Farzaneh, et al.. (2019). Cloning, expression and characterization of a HER2-alpha luffin fusion protein inEscherichia coli. Preparative Biochemistry & Biotechnology. 49(8). 759–766. 8 indexed citations

Cohan, Reza Ahangari, Dariush Norouzian, Fatemeh Davami, et al.. (2019). Enhancing bioactivity, physicochemical, and pharmacokinetic properties of a nano-sized, anti-VEGFR2 Adnectin, through PASylation technology. Scientific Reports. 9(1). 2978–2978. 23 indexed citations

Barkhordari, Farzaneh, et al.. (2018). Cloning and soluble expression of mature α-luffin from Luffa cylindrica inE. coli using SUMO fusion protein. TURKISH JOURNAL OF BIOLOGY. 42(1). 23–32. 6 indexed citations

10.

Davami, Fatemeh, et al.. (2017). Monoclonal antibodies expression improvement in CHO cells by PiggyBac transposition regarding vectors ratios and design. PLoS ONE. 12(6). e0179902–e0179902. 19 indexed citations

11.

Vaziri, Behrouz, et al.. (2017). Proteomics Profiling of Chimeric-Truncated Tissue Plasminogen activator Producing- Chinese Hamster Ovary Cells Cultivated in a Chemically Defined Medium Supplemented with Protein Hydrolysates. Iranian Biomedical Journal. 21(3). 154–166. 4 indexed citations

12.

Rouini, Mohammad Reza, Esmat Mirabzadeh, Behrouz Vaziri, et al.. (2017). Scale up and pharmacokinetic study of a novel mutated chimeric tissue plasminogen activator (mt-PA) in rats. Scientific Reports. 7(1). 43028–43028. 5 indexed citations

13.

Mahboudi, Fereidoun, et al.. (2017). Evaluating the expression profile and stability of different UCOE containing vector combinations in mAb-producing CHO cells. BMC Biotechnology. 17(1). 18–18. 26 indexed citations

14.

Torkashvand, Fatemeh, Behrouz Vaziri, Shayan Maleknia, et al.. (2015). Designed Amino Acid Feed in Improvement of Production and Quality Targets of a Therapeutic Monoclonal Antibody. PLoS ONE. 10(10). e0140597–e0140597. 51 indexed citations

15.

Davami, Fatemeh, Soroush Sardari, Keivan Majidzadeh‐A, et al.. (2011). A novel variant of t-PA resistant to plasminogen activator inhibitor-1; expression in CHO cells based on In Silico experiments. BMB Reports. 44(1). 34–39. 16 indexed citations

16.

Davami, Fatemeh. (2011). Combined TGE-SGE Expression of Novel PAI-1-Resistant t-PA in CHO DG44 Cells Using Orbitally Shaking Disposable Bioreactors. Journal of Microbiology and Biotechnology. 21(12). 1299–1305. 8 indexed citations

17.

Davami, Fatemeh, Soroush Sardari, Keivan Majidzadeh‐A, et al.. (2010). Expression of a Novel Chimeric Truncated t-PA in CHO Cells Based on in Silico Experiments. SHILAP Revista de lepidopterología. 2010. 1–9. 23 indexed citations

18.

Majidzadeh‐A, Keivan, et al.. (2010). Cloning and Expression of Functional Full-Length Human Tissue Plasminogen Activator in Pichia pastoris. Applied Biochemistry and Biotechnology. 162(7). 2037–2048. 13 indexed citations

19.

Mahboudi, Fereidoun, Keivan Majidzadeh‐A, Fatemeh Davami, et al.. (2010). Increased expression of recombinant human tissue plasminogen activator in Leishmania tarentolae. Biotechnology Journal. 5(11). 1198–1206. 17 indexed citations

20.

Oveisi, Mohammad Reza, Mannan Hajimahmoodi, & Fatemeh Davami. (2003). SIMULTANEOUS SPECTROPHOTOMETRIC DETERMINATION OF MIXTURES OF FOOD COLORANTS. DARU Journal of Pharmaceutical Sciences. 11(1). 1–6. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact